Cargando…

Exercise training as a novel primary treatment for localised prostate cancer: a multi-site randomised controlled phase II study

Alternative management strategies for localised prostate cancer are required to reduce morbidity and overtreatment. The aim of this study was to evaluate the feasibility, safety and acceptability of exercise training (ET) with behavioural support as a primary therapy for low/intermediate risk locali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bourke, L., Stevenson, R., Turner, R., Hooper, R., Sasieni, P., Greasley, R., Morrissey, D., Loosemore, M., Fisher, A., Payne, H., Taylor, S. J. C., Rosario, D. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976628/ https://www.ncbi.nlm.nih.gov/pubmed/29849032 http://dx.doi.org/10.1038/s41598-018-26682-0

Ejemplares similares

Towards implementing exercise into the prostate cancer care pathway: development of a theory and evidence-based intervention to train community-based exercise professionals to support change in patient exercise behaviour (The STAMINA trial)
por: Reale, Sophie, et al.
Publicado: (2021)

Treatment in the STAMPEDE era for castrate resistant prostate cancer in the UK: ongoing challenges and underappreciated clinical problems
por: Greasley, Rosa U., et al.
Publicado: (2018)

Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness?
por: Bourke, L, et al.
Publicado: (2013)

The development of a theory and evidence-based intervention to aid implementation of exercise into the prostate cancer care pathway with a focus on healthcare professional behaviour, the STAMINA trial
por: Turner, Rebecca R., et al.
Publicado: (2021)

A multi-centre investigation of delivering national guidelines on exercise training for men with advanced prostate cancer undergoing androgen deprivation therapy in the UK NHS
por: Bourke, Liam, et al.
Publicado: (2018)

Embedding supervised exercise training for men on androgen deprivation therapy into standard prostate cancer care: a feasibility and acceptability study (the STAMINA trial)
por: Reale, Sophie, et al.
Publicado: (2021)

A randomised trial of robotic and open prostatectomy in men with localised prostate cancer
por: Gardiner, Robert A, et al.
Publicado: (2012)

Exercise training to increase tumour natural killer‐cell infiltration in men with localised prostate cancer: a randomised controlled trial
por: Djurhuus, Sissal Sigmundsdóttir, et al.
Publicado: (2022)

A profile of enzalutamide for the treatment of advanced castration resistant prostate cancer
por: Greasley, Rosa, et al.
Publicado: (2015)

ROLLIS roll‐out: Pitfalls, errors, lessons learned and recommendations from Australian and New Zealand experience during the randomised controlled trial, implementing a novel localisation method for impalpable malignant breast lesions, radio‐guided occult lesion localisation with iodine‐125 ((125)I) seed (ROLLIS)
por: Bourke, Anita G, et al.
Publicado: (2022)

Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial
por: Sanghera, S., et al.
Publicado: (2020)

Patient preferences for treatment modalities for localised prostate cancer
por: Teunissen, Frederik R., et al.
Publicado: (2022)

Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2013)

Long-term outcome among men with conservatively treated localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2006)

Feasibility study of a randomised controlled trial to compare (deferred) androgen deprivation therapy and cryotherapy in men with localised radiation-recurrent prostate cancer
por: Salji, M, et al.
Publicado: (2014)

Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study
por: Catto, J W F, et al.
Publicado: (2011)

The modern role of androgen deprivation therapy in the management of localised and locally advanced prostate cancer
por: Gunner, Charlotte, et al.
Publicado: (2016)

Men's help‐seeking in the first year after diagnosis of localised prostate cancer
por: Hyde, M.K., et al.
Publicado: (2016)

Current Trends in the Management of Localised Prostate Cancer
por: Sibley, G. N. A., et al.
Publicado: (1992)

Differential proteomic alterations between localised and metastatic prostate cancer
por: Taylor, B S, et al.
Publicado: (2006)

Response to comment on ‘Interventions to improve exercise behaviour in sedentary people living with and beyond cancer: a systematic review'
por: Bourke, L, et al.
Publicado: (2014)

Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)
por: Lane, Janet Athene, et al.
Publicado: (2022)

Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer
por: King, M T, et al.
Publicado: (2012)

Impact of differential cyclin D1 expression and localisation in prostate cancer
por: Comstock, C E S, et al.
Publicado: (2007)

Reply: Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness?
por: Rosario, D J, et al.
Publicado: (2013)

The potential for enhanced tumour localisation by poly(ethylene glycol) modification of anti-CEA antibody.
por: Pedley, R. B., et al.
Publicado: (1994)

Nurse-led group consultation intervention reduces depressive symptoms in men with localised prostate cancer: a cluster randomised controlled trial
por: Schofield, Penelope, et al.
Publicado: (2016)

Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy
por: Maspero, Matteo, et al.
Publicado: (2018)

Androgen deprivation therapy as adjuvant/neoadjuvant to radiotherapy for high-risk localised and locally advanced prostate cancer: recent developments
por: Payne, H, et al.
Publicado: (2011)

Localisation of volatile isotopes on cryotraps
por: Neumayr, J.B, et al.
Publicado: (23/0)

Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study
por: Berney, D M, et al.
Publicado: (2009)

Localised Arterial Thrombosis of Indeterminate Origin
por: Learmonth, J. R., et al.
Publicado: (1944)

ProsCan for Men: Randomised controlled trial of a decision support intervention for men with localised prostate cancer
por: Chambers, Suzanne K, et al.
Publicado: (2008)

Kank Is an EB1 Interacting Protein that Localises to Muscle-Tendon Attachment Sites in Drosophila
por: Clohisey, Sara M. R., et al.
Publicado: (2014)

Heterogeneous localisation of membrane proteins in Staphylococcus aureus
por: Weihs, Felix, et al.
Publicado: (2018)

Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer
por: Elliott, Daisy, et al.
Publicado: (2018)

Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis
por: Xiong, Tengbin, et al.
Publicado: (2014)

Prostate cancer–Exercise and Metformin Trial (Pre-EMpT): study protocol for a feasibility factorial randomized controlled trial in men with localised or locally advanced prostate cancer
por: McGeagh, Lucy, et al.
Publicado: (2022)

Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan® localisation in cultured tumour cells
por: Teiten, M-H, et al.
Publicado: (2003)

Remote interventions to improve exercise behaviour in sedentary people living with and beyond cancer: a systematic review and meta-analysis
por: Ibeggazene, Saïd, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vrhqto3820ta8308enmcp44a3r